AZN
AZN
AstraZeneca PLC
$185.51
-$2.21 (-1.18%)
Mkt Cap: $287.70B
Home / AZN / Financial Statements

AstraZeneca PLC (AZN) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$60.44B
$58.74B ↑8.6%
$54.07B ↑18.0%
$45.81B ↑3.3%
$44.35B ↑18.5%
$37.42B
Cost of Revenue
$11.07B
$10.63B ↑4.2%
$10.21B ↑23.5%
$8.27B ↓33.3%
$12.39B ↓0.4%
$12.44B
Gross Profit
$49.37B
$48.11B ↑9.7%
$43.87B ↑16.8%
$37.54B ↑17.5%
$31.96B ↑27.9%
$24.98B
R&D Expenses
$14.56B
$14.23B ↑4.8%
$13.58B ↑24.2%
$10.94B ↑12.0%
$9.76B ↑0.3%
$9.74B
SG&A Expenses
$20.95B
$20.51B ↑1.4%
$20.22B ↑11.0%
$18.22B ↑1.3%
$17.98B ↑15.4%
$15.59B
Operating Income
$14.31B
$13.74B ↑37.4%
$10.00B ↑22.1%
$8.19B ↑118.1%
$3.76B ↑255.8%
$1.06B
Interest Expense
$1.74B
$1.69B ↑0.7%
$1.68B ↑5.9%
$1.59B ↑19.5%
$1.33B ↑4.2%
$1.28B
Income Tax
$2.52B
$2.17B ↑31.5%
$1.65B ↑75.9%
$938.00M ↑218.4%
-$792.00M ↓108.4%
-$380.00M
Net Income
$10.39B
$10.26B ↑45.8%
$7.04B ↑18.1%
$5.96B ↑81.1%
$3.29B
$112.00M
EBITDA
$20.47B
$19.83B ↑28.4%
$15.44B ↑15.0%
$13.42B ↑47.7%
$9.09B ↑77.7%
$5.11B
EPS
6.64
6.54 ↑190.7%
2.25 ↓40.9%
3.81 ↑80.6%
2.11
0.08
Shares Out (Diluted)
6.24B
1.56B ↓0.1%
1.56B ↑0.1%
1.56B ↑0.1%
1.56B ↑9.3%
1.43B